Sumitomo Pharma To Fortify R&D, Pay Off Debt Through $730m Stock Offering

Prioritizing Late-Stage Oncology Candidates

 
• By Lisa Takagi
  
Sumitomo stock offering
Sumitomo Pharma raising new funds to support R&D, pay back loans (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Cell Therapies